190386-37-9Relevant academic research and scientific papers
Biocatalytic Site-Selective Hydrogen Isotope Exchange of Unsaturated Fragments with D2O
Wang, Lanlan,Lou, Yujiao,Xu, Weihua,Chen, Zhichun,Xu, Jian,Wu, Qi
, p. 783 - 788 (2022/01/15)
Deuterated unsaturated fragments have gained increasing attention because of their roles in understanding reaction mechanisms and pharmaceutical potentials. Due to the difficulties of the existing synthetic methods, it is highly desirable to develop an ef
Spontaneous conversion of prenyl halides to acids: application in metal-free preparation of deuterated compounds under mild conditions
Darshana, Dhanushka,Sureram, Sanya,Mahidol, Chulabhorn,Ruchirawat, Somsak,Kittakoop, Prasat
supporting information, p. 7390 - 7402 (2021/09/07)
Here we reveal a simple generation of deuterium halide (DX) from common and inexpensive reagents readily available in a synthetic chemistry laboratory,i.e. prenyl-, allyl-, and propargyl halides, under mild conditions. We envisaged thatin situgeneration of an acid, deuterium halide, would be useful for acid-catalyzed reactions and could be employed for organocatalytic deuteration. The present work reports a metal-free method for deuterium labeling covering a broad range of substrate including phenolic compounds (i.e. flavonoids and stilbenes), indoles, pyrroles, carbonyl compounds, and steroids. This method was also applied for commonly used drugs such as loxoprofen, haloperidol, stanolone, progesterone, androstenedione, donepezil, ketorolac, adrenosterone, cortisone, pregnenolone, and dexamethasone. A gram-scale chromatography-free synthesis of some deuterated compounds is demonstrated in this work. This work provides a simple, clean and by-product-free, site-selective deuteration, and the deuterated products are obtained without chromatographic separation. When applying these initiators for other acid-catalyzed reactions, the deuterium isotope effects of DX may provide products which are different from those obtained from reactions using common acids. Although the mechanism of the spontaneous transformation of prenyl halides to acid is unclear, this overlooked chemistry may be useful for many reactions.
Shifted Selectivity in Protonation Enables the Mild Deuteration of Arenes through Catalytic Amounts of Bronsted Acids in Deuterated Methanol
Fischer, Oliver,Hubert, Anja,Heinrich, Markus R.
, p. 11856 - 11866 (2020/10/23)
Taking advantage of the "differentiating effect"of the solvent methanol, deuterations of electron-rich aromatic systems can be carried out under mild acid catalysis and thus under far milder conditions than known so far. The exceptional functional group t
Iron-catalysed tritiation of pharmaceuticals
Pony Yu, Renyuan,Hesk, David,Rivera, Nelo,Pelczer, Istvan,Chirik, Paul J.
, p. 195 - 199 (2016/01/25)
A thorough understanding of the pharmacokinetic and pharmacodynamic properties of a drug in animal models is a critical component of drug discovery and development. Such studies are performed in vivo and in vitro at various stages of the development process-ranging from preclinical absorption, distribution, metabolism and excretion (ADME) studies to late-stage human clinical trials-to elucidate a drug molecule's metabolic profile and to assess its toxicity. Radiolabelled compounds, typically those that contain 14C or 3H isotopes, are one of the most powerful and widely deployed diagnostics for these studies. The introduction of radiolabels using synthetic chemistry enables the direct tracing of the drug molecule without substantially altering its structure or function. The ubiquity of C-H bonds in drugs and the relative ease and low cost associated with tritium (3H) make it an ideal radioisotope with which to conduct ADME studies early in the drug development process. Here we describe an iron-catalysed method for the direct 3H labelling of pharmaceuticals by hydrogen isotope exchange, using tritium gas as the source of the radioisotope. The site selectivity of the iron catalyst is orthogonal to currently used iridium catalysts and allows isotopic labelling of complementary positions in drug molecules, providing a new diagnostic tool in drug development.
